Innovations Advancing Vaccine Preparedness and Response Capabilities to Counter Pandemic Influenza
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 963
Special Issue Editors
Interests: influenza; emerging infectious diseases; preclinical and clinical development of vaccines; pandemic response
Special Issues, Collections and Topics in MDPI journals
Interests: influenza vaccine development strategy and manufacturing technology
Interests: human influenza; zoonotic influenza; pandemic; pandemic preparedness; avian influenza; influenza virus; influenza immune response; influenza vaccine
Special Issue Information
Dear Colleagues,
The following Special Issue invites original contributions that propose or demonstrate innovations across the entire target product profile of candidate influenza vaccines. These innovations aim to surpass currently available vaccines in key metrics such as efficacy, durability, breadth of protection, development speed, adaptability, and ease of administration. We are particularly interested in novel vaccine candidates leveraging "platform technologies" (e.g., nucleic acid, recombinant proteins, and viral vectors) that can significantly expedite the development timeline for pandemic vaccines from initial sequence identification to regulatory approval and mass deployment.
We welcome submissions covering the following topics of interest:
- New vaccine mechanisms of action, high efficacy, and safety.
- Seasonal vaccines with the potential to convey some level of immunity to an emerging zoonotic influenza virus.
- Passive immunization or Pre-Exposure Prophylaxis (PrEP) with monoclonal antibodies
- Manufacturing platform speed, yield, and capacity.
- Clinical trial acceleration and correlates of protection.
- Enabling technologies and strategies, including the following:
- New or improved immune assays to support product development;
- New or improved assays to understand antigenic drift and escape from vaccine immunity.
- Accessibility, impact, and sustainability, including the following:
- Single-dose regimens;
- Alternative routes of administration;
- Vaccine uptake.
Dr. Ruben Donis
Dr. Sam Lee
Dr. Christine Oshansky
Dr. Leah Watson
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- influenza vaccines
- efficacy
- vaccine uptake
- rapid manufacturing
- vaccine mechanism of action
- alternative routes of administration
- single-dose regimens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
